US 11,717,563 B2
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
Marc Mansour, Halifax (CA); Leeladhar Sammatur, Irvine, CA (US); Lisa Diana MacDonald, Halifax (CA); Mohan Karkada, Rockville, MD (US); Genevieve Mary Weir, Medford, MA (US); and Antar Fuentes-Ortega, Lac des Arcs (CA)
Assigned to IMMUNOVACCINE TECHNOLOGIES INC., Dartmouth (CA)
Filed by IMMUNOVACCINE TECHNOLOGIES INC., Dartmouth (CA)
Filed on Feb. 22, 2019, as Appl. No. 16/283,486.
Application 16/283,486 is a continuation of application No. 12/992,512, abandoned, previously published as PCT/CA2009/000692, filed on May 22, 2009.
Claims priority of provisional application 61/059,043, filed on Jun. 5, 2008.
Prior Publication US 2019/0290743 A1, Sep. 26, 2019
Int. Cl. A61K 39/00 (2006.01); A61K 9/127 (2006.01); A61K 9/10 (2006.01); A61K 31/7088 (2006.01); A61K 9/107 (2006.01); A61K 47/06 (2006.01); A61K 9/19 (2006.01); A61K 31/785 (2006.01)
CPC A61K 39/00 (2013.01) [A61K 9/10 (2013.01); A61K 9/107 (2013.01); A61K 9/127 (2013.01); A61K 9/19 (2013.01); A61K 31/785 (2013.01); A61K 47/06 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); Y02A 50/30 (2018.01)] 26 Claims
 
1. A composition, comprising:
(a) an antigen that is expressed by a tumor cell;
(b) liposomes;
(c) a DNA-based polyI:C polynucleotide; and
(d) a carrier comprising a continuous phase of a hydrophobic substance.